BCS1L Inhibitors

Chemical inhibitors of BCS1L target various components of the mitochondrial electron transport chain (ETC), each affecting the assembly and function of Complex III, which BCS1L is intimately involved in. Antimycin A directly inhibits the bc1 complex, impeding the electron transport at a juncture critical for the functional integrity of Complex III. Similarly, Myxothiazol and Stigmatellin bind to different sites on the cytochrome b subunit of the bc1 complex, leading to inhibition of electron transport through Complex III. Both actions can result in an indirect inhibition of BCS1L by preventing the proper assembly of Complex III due to the lack of electron flow through the bc1 complex. Carboxin and Thenoyltrifluoroacetone (TTFA) target Complex II, creating an electron backlog that can disturb the overall flow through the ETC, impacting the assembly of Complex III and the role of BCS1L therein. Disruptions in Complex II function can lead to an accumulation of electrons, which compromises the proton gradient necessary for ATP synthesis and indirectly affects the BCS1L-associated process of Complex III assembly.

The second set of inhibitors, including Aurovertin B and Oligomycin, target ATP synthase (Complex V). These inhibitors cause a buildup of the proton gradient, which indirectly could lead to reduced efficiency of Complex III assembly, where BCS1L is critical. Rotenone and Piericidin A, as inhibitors of electron transport at Complex I, can induce a domino effect, leading to a dysfunctional ETC that indirectly impacts BCS1L's role in Complex III. By hampering the initial step of electron transport, these inhibitors can lead to a dysfunctional ETC, which affects the assembly process of Complex III involving BCS1L. Zinc Pyrithione disrupts the respiratory chain, thereby affecting BCS1L's functionality due to the compromised electron transport and membrane potential, which are crucial for Complex III assembly. FCCP acts as an uncoupler, collapsing the proton gradient, which can result in an indirect inhibition of BCS1L's role in Complex III assembly. Lastly, the use of Iodinated Contrast Media like Iohexol can interfere with mitochondrial function broadly, disrupting the ETC and thereby indirectly affecting BCS1L's role in the biogenesis of Complex III.